UNICEF and Lilly Collaborate to Improve Health Outcomes for 10 Million patients with chronic, non-communicable diseases

0 35

Through 2025, Eli Lilly and Company and UNICEF will collaborate to help 10 million children and adolescents living with chronic non-communicable diseases (NCDs) improve their health outcomes.

Lilly has pledged $14.4 million to UNICEF’s lifesaving efforts in Bangladesh, Malawi, Nepal, the Philippines, and Zimbabwe1 to address NCD risk factors, strengthen health systems, and improve the ability of health care personnel to care for patients. The nations were chosen for their geographic diversity and the potential to improve country-level health systems and models that provide care and support for children and adolescents with chronic illnesses.

According to the Global Burden of Disease Study, almost one million people under the age of 20 die each year from non-communicable diseases such as type 1 diabetes, cancer, congenital and rheumatic heart disease, sickle cell disease, and asthma, all of which are often treatable. These deaths account for 15% of this age group’s overall mortality.

“No child should die from a treatable disease because of inadequate care or treatment. Non-communicable diseases undermine a child’s right to health, nutrition, education, and play. We are grateful to Lilly for this collaboration to help strengthen health care systems children rely on and ensure health care workers are well-equipped and confident in providing care and treatment to children living with chronic conditions,”

said Karin Hulshof, Deputy Executive Director, UNICEF.

This four-year commitment reflects Lilly and UNICEF’s joint efforts to advance the UN Sustainable Development Goals (SDGs), particularly SDG3, which aims to ensure healthy lives and promote well-being for all people of all ages.

“UNICEF’s relentless work to reach disadvantaged children, combined with Lilly’s experience and deep commitment to bettering people’s lives and society, serves as the foundation of this collaborative effort. This critical, lifesaving work by UNICEF is aligned to the Lilly 30×30 initiative to provide improved access to quality health care for 30 million people in resource-limited settings, annually, by 2030,” s

aid David A. Ricks, chair and CEO of Lilly.

Strengthening NCD data and health information systems; establishing and strengthening NCD prevention, care, and treatment within primary health care and referral facilities (e.g., capacity building of local health care providers including training, mentorship, remote patient monitoring, and so on); and capacity building of service providers for NCD screening and improved management and treatment will be among the interventions in the five countries.

Leave A Reply

Your email address will not be published.